SPOTLIGHT -
Treatment failure risk is high, new biomarker of conversion from major depressive disorder, depression stifles creativity, and other recent findings are summarized here.
Psychiatry in the News: October 2023
Blue Light, Depression, and Bipolar Disorder
Study Finds Connection Between Olanzapine/Samidorphan and Reduced Health Care Utilization in Patients With Schizophrenia, Bipolar I
Four Myths About Lamotrigine
The Week in Review: September 18-22
How Do Treatments for Bipolar Disorder and SUD Affect One Another?